License

License Not Specified

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Phase IbIIa study of combination therapy with Gemcitabine and Atu027 in subjects with locally advanced or metastatic pancreatic adenocarcinoma

The primary objectives of this study are to evaluate the safety and pharmacokinetics of Atu027 when used in combination with gemcitabine in subjects with locally advanced or metastatic pancreatic adenocarcinoma

FieldValue
Modified
2019-12-23
Release Date
2019-04-30
Identifier
055bff04-5028-4dea-a5d8-67c1ac70fd6e
License
License Not Specified
Public Access Level
Public